RxDoctor Payments Data

Michael Richards

Pediatrics · Minneapolis, MNNPI 1699741652

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Octapharma USA, Inc.. That places this record below the midpoint for pediatrics clinicians in MN, where the typical reported total is $64.

$55in general payments, 2019–2025

Across 1 payment — averaging $54.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Octapharma USA, Inc.$55
$1,342,923in research payments, 2019–2025

Across 128 payments — averaging $10,492 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Jazz Pharmaceuticals Inc.$1.2M
  • Merck$73K
  • Incyte Corporation$43K
  • Gilead$20K
  • Pfizer$3K

What the payments were for

  • Food & beverage$55100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Octapharma USA, Inc.1$55

How this compares

$55 in reported general payments places this provider in the 45th percentile of 397 pediatrics providers in Minnesota.

See all pediatrics providers in Minnesota

Other pediatrics in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →